4.5 Article

Serum IGF1 and linear growth in children with congenital leptin deficiency before and after leptin substitution

Journal

INTERNATIONAL JOURNAL OF OBESITY
Volume 45, Issue 7, Pages 1448-1456

Publisher

SPRINGERNATURE
DOI: 10.1038/s41366-021-00809-2

Keywords

-

Funding

  1. Obesity and Lipodystrophy Center at the Endocrinology Unit, University Hospital of Pisa, Pisa, Italy
  2. Hertha-Nathorff-Program of the Medical Faculty of the University of Ulm [LSSH1000.07, KSKI 002.1]
  3. German Federal Ministry of Education and Research (BMBF) as part of the German Competence Network Obesity (Consortium Youth with Extreme Obesity) [01GI1120A/B]
  4. HEXAL AG
  5. Projekt DEAL

Ask authors/readers for more resources

This study investigated the effect of leptin substitution on growth factors and linear growth in children with congenital leptin deficiency (CLD). The results showed that leptin substitution significantly increased IGF1 levels and promoted linear growth, contrary to observations in children with idiopathic obesity.
Background Evidence from in vitro and rodent studies suggests that leptin, a key signal of long-term energy reserves, promotes IGF1 synthesis and linear growth. This effect of leptin has not been fully investigated in humans. The aim of our study was to investigate the effect of leptin substitution on growth factors and linear growth in children with congenital leptin deficiency (CLD). Methods In this cohort study we included eight pediatric patients (six males), age 0.9-14.8 years, who were diagnosed with CLD and received leptin substitution at our University Medical Center. We calculated standard deviation scores (SDS) for serum levels of IGF1 and IGFBP3, IGF1/IGFBP3 molar ratio, and height at baseline (T0) and 12 months (T12) after the initiation of substitution with metreleptin. Results All patients had severe obesity (BMI-SDS mean +/- SD: 4.14 +/- 1.51) at T0 and significant BMI-SDS reduction to 2.47 +/- 1.05 at T12. At T0, all patients were taller than the mid-parental median, yet had low IGF1 and IGF1/IGFBP3 molar ratios (IGF1-SDS (x) over bar (T0): -1.58 +/- 0.92, IGF1/IGFBP3 molar ratio-SDS (x) over bar (T0): -1.58 +/- 0.88). At T12, IGF1-SDS increased significantly (Delta(T0-12): 1.63 +/- 1.40, p = 0.01), and IGFBP3-SDS and IGF1/IGFBP3 molar ratio-SDS showed a trend toward an increase. In the three children within the childhood growth period (post-infancy, pre-puberty) height-SDS increased (Delta height-SDST0-12: 0.57 +/- 0.06, p = 0.003) despite substantial weight loss. Conclusions These results in CLD patients are contrary to observations in children with idiopathic obesity who typically have above-mean IGF1 levels that decrease with weight loss, and therefore suggest that leptin increases IGF1 levels and promotes linear growth.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available